Qiming Venture Partners

Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Cyrus Chan

Associate

Nan Chen

Principal

David Chu

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Vice President

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho

Venture Partner

William Hu

Managing Partner

Duane Kuang

Co-Founder and Managing Partner

Nisa Leung

Managing Partner

Dingzheng Li

Vice President

Jing Liu

Vice President

Chang Liu

Associate

Bin Liu

Vice President

Biao Lu

Associate

Shuo Mao

Principal

Will McConnell

Principal

Gary Rieschel

Founder and Managing Partner

James Shen

Venture Partner

Motao Sun

Vice President

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Rachel Wang

Venture Partner

James Wang

Venture Partner

Jing Wu

Partner

Gillian Xu

RMB funds CFO

Peter (Ming) Yin

Principal, Cleantech

Janet Yu

Partner

Oscar Zhang

Principal

Yafeng Zhou

Associate

Alex Zhou

Partner

Zhiyuan Zhou

Associate

Zhifeng Zhou

Managing Partner

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Phillip DiGiacomo Ph.D

Principal

Past deals in Embedded Software

Force Inspiration

Angel Round in 2025
Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robot manufacturing and sales.

Inexbot

Series A in 2023
iNexBot specializes in the development and manufacturing of robot motion controllers and industrial robot intelligence technology. The company focuses on creating solutions for various sectors, including industrial robotics, collaborative robotics, semiconductors, healthcare automation, and automotive electronics. iNexBot's offerings encompass advanced robot motion control systems, machine vision technology, laser seam tracking technology, and other essential robot hardware. By providing both hardware and software, iNexBot equips robot manufacturers with the necessary tools to enhance their robotic products and improve operational efficiency across multiple industries.

CIX Technology

Series A in 2023
CIX Technology specializes in developing advanced intelligent computing solutions, focusing on high-performance, energy-efficient general-purpose computing chips and CPUs. Utilizing ARM architecture, the company designs its products for a variety of applications, including notebooks, desktops, high-end tablets, and augmented/virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to create more efficient electronics and other technological products, ultimately improving computing speed and performance across various sectors.

Bitworx

Series A in 2022
Bitworx is a company based in Chengdu, China, specializing in product development and applications that leverage advanced algorithm and chip technology for communication, sensing, and detection. Currently, Bitworx is operating in stealth mode, which indicates that it is in the early stages of its business activities and may not yet be publicly disclosing its specific projects or technologies. The focus on communication and sensing technologies suggests a commitment to innovation in fields that require precise detection and data transmission capabilities.

CIX Technology

Seed Round in 2022
CIX Technology specializes in developing advanced intelligent computing solutions, focusing on high-performance, energy-efficient general-purpose computing chips and CPUs. Utilizing ARM architecture, the company designs its products for a variety of applications, including notebooks, desktops, high-end tablets, and augmented/virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to create more efficient electronics and other technological products, ultimately improving computing speed and performance across various sectors.

CIX Technology

Angel Round in 2022
CIX Technology specializes in developing advanced intelligent computing solutions, focusing on high-performance, energy-efficient general-purpose computing chips and CPUs. Utilizing ARM architecture, the company designs its products for a variety of applications, including notebooks, desktops, high-end tablets, and augmented/virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to create more efficient electronics and other technological products, ultimately improving computing speed and performance across various sectors.

Element Science

Series C in 2020
Element Science, Inc. is a medical device and digital health company focused on developing solutions for high-risk cardiovascular patients. The company's flagship product is a patch-based wearable cardioverter defibrillator that continuously monitors heart activity to protect against sudden cardiac death. This device integrates advanced data science and machine learning algorithms with strict electromechanical medical device standards, creating a proprietary digital platform that enhances patient care as individuals transition from hospital to home. Founded in 2011 and headquartered in San Francisco, California, Element Science aims to address critical health needs and reduce hospitalization rates associated with heart disease. The company was previously known as Revive Defibrillation Systems, Inc. before adopting its current name in 2014.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.